INTRODUCTION
Tumor biology, immunology, and immune-oncology from multi-omics at the single cell level have witnessed an unprecedented acceleration in recent years, with a major contribution of such speedup from new technologies and products bursting into the market. New technological solutions also contributed deterministically to the promise of cell-based therapy. However, conventional cell separation tools, such as density-gradient-based centrifugation, column-based magnetic cell separation, and even FACS (fluorescent activated cell sorting) have become limiting factors to broadening the application of single cell analysis from complex tissues samples and very rare cell types. In the development of cell therapy drugs, robust cell manufacturing platforms that are flexible, adaptable to various processes, and involve minimal human factors, are also widely sought after.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
We divide cookies into necessary cookies and third-party cookies that relate to functionality, technical issues and the collection of statistical and marketing data. No consent to third-party cookies allows you to continue using the website.
If you are looking for more information, we invite you to read our privacy policy.